Latest Breaking News On - Biosplice chief medical officer - Page 1 : vimarsana.com

Biosplice Presents Successful Structure and Pain Results

Biosplice Therapeutics Inc. presents results of OA-07 Long-Term Extension Trial for its knee OA drug candidate, lorecivivint..

United statesSan diegoYusuf yaziciErich horsleyAmerican college of rheumatologyBiosplice therapeutics incBiosplice chief medical officerBiosplice therapeuticsKnee osteoarthritisClinical trial data

Biosplice Announces Interim Data from Phase 3 Long-Term

Unique interim X-ray results from an ongoing long-term extension study suggest structure-modifying benefit of repeat injections of lorecivivint, as.

Yusuf yaziciBiosplice therapeutics incBiosplice chief medical officerAmerican conferenceRheumatology annual meetingBiosplice therapeuticsBiosplice therapeuticsClinical trials

Biosplice Publishes Phase 2B Lorecivivint Analysis Showing

Biosplice Publishes Phase 2B Lorecivivint Analysis Showing
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

Yusuf yaziciErich horsleyBiosplice therapeutics incBiosplice chief medical officerஎரிச் ஹார்ஸ்லி